April 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountiris-pharma.com
Global Rank
#11,132,017
1,385,729Country Rank
- -
Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
35.87%
Pages per Visit
2.07
Avg Visit Duration
00:00:42
- Company
- Iris Pharma
Top 10 iris-pharma.com Competitors
The Top 10 Sites Like iris-pharma.com in April 2026 are ranked by their affinity to iris-pharma.com in terms of keyword traffic, audience targeting, and market overlap
At the Amercian Academy of Opthalmology 115th Annual Meeting, findings were presented from a retrospective study conducted after a Mayo Clinic opthalmologist
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
100%syneos health is the only fully integrated biopharmaceutical solutions organization. our company, including a contract research organization (cro) and contract commercial organization (cco), is purpose-built to accelerate customer performance to address modern market realities. created through the merger of two industry-leading companies – inc research and inventiv health – we
- Company
- INC Research
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
97%Celerion is committed to implementing innovative strategies with applied translational medicine to gain insights on early drug development decisions. We provide vital expertise and experience in a large clinical capacity to ensure our clients are getting their product to the market faster.
- Company
- Celerion
Global Rank
#1,379,968
23,601Bounce Rate
46.69%
Pages per Visit
1.66
Avg Visit Duration
00:00:21
Similarity Score
95%- Company
- - -
- Industry
- - -
Global Rank
#6,237,937
2,789,078Bounce Rate
37.36%
Pages per Visit
1.06
Avg Visit Duration
- -
Similarity Score
95%former two words, brandable .com domain being an info blog made to keep readers up-to-date with the latest happenings in the pharmaceutical industry.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
95%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
59%CGIRB is a fully accredited independent institutional review board based in Durham, N.C. CGIRB’s primary responsibility is to ensure that the rights and welfare of human research subjects are protected.
- Company
- Copernicus Group
- Industry
- Health > Health - Other
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
58%daily news on pharmaceutical outsourcing. free access to news on pharmaceutical supply, pharmaceutical manufacturing, contract research and pharmaceutical services
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
58%- Company
- - -
- Industry
- - -
Global Rank
#5,112,405
554,503Bounce Rate
53.05%
Pages per Visit
1.72
Avg Visit Duration
00:00:32
Similarity Score
58%iris-pharma.com's top 5 competitors in April 2026 are: eyecro.com, incresearch.com, celerion.com, resverlogix.com, and more.
According to Similarweb data of monthly visits, iris-pharma.com’s top competitor in April 2026 is eyecro.com. iris-pharma.com 2nd most similar site is incresearch.com, and closing off the top 3 is celerion.com.
resverlogix.com ranks as the 4th most similar website to iris-pharma.com and pharmaasia.com ranks fifth in April 2026.
The other five competitors in the top 10 list are kendle.com, copernicusgroup.com, drugresearcher.com, newtbdrugs.org, and .